Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 5:10 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 961–984 of 1,600 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Skin Patch Clear all

Conditions: Schizophrenia, Psychopathology, Nicotine Dependence
Interventions: Not listed
Lead sponsor: National Institute on Drug Abuse (NIDA); NIH
Eligibility: 18 Years to 50 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2012
U.S. locations: 1
States / cities: Catonsville, Maryland

Conditions: Cardiac Arrhythmia
Interventions: Not listed
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Melanoma
Interventions: Skin Self Examination Information and ABCDE Rule; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2010
U.S. locations: 3
States / cities: Chicago, Illinois • Maywood, Illinois • Lebanon, New Hampshire

Conditions: Obesity, Overweight, Cigarette Smoking
Interventions: semaglutide 2.4mg, Placebo, Nicotine Replacement Therapy (NRT, nicotine patch), Brief Smoking Cessation Counseling; Drug · Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 75 Years
Enrollment: 197 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 2
States / cities: Austin, Texas • Houston, Texas

Conditions: Menopause, Estrogen Deficiency, Aging, Adiposity
Interventions: Degarelix, Transdermal Estradiol Patch, Transdermal Placebo Patch; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 20 Years to 45 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Chronic, Non Malignant Pain
Interventions: EN3270; Drug
Lead sponsor: Durect; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Berlin, New Jersey

Conditions: Alzheimer Disease, Healthy Aging
Interventions: BrightGo cognitive training, Standard of Care medication for early Alzheimer's Disease; Device · Drug
Lead sponsor: Bright Cloud International Corp; Industry
Eligibility: 65 Years to 85 Years
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 2
States / cities: New Brunswick, New Jersey • North Brunswick, New Jersey

Conditions: Smoking Cessation
Interventions: nicotine polacrilex, nicotine transdermal system, nicotine inhaler; Drug
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Bone Strength, Bone Density, FHA (Functional Hypothalamic Amenorrhea)
Interventions: transdermal 17β-E2 with cyclic progestin, oral 17β-E2 with cyclic progestin, transdermal EE+LNG; Drug
Lead sponsor: University of Virginia; Other
Eligibility: 14 Years to 30 Years · Female only
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 2
States / cities: Charlottesville, Virginia

Conditions: Asthma in Children, Allergy
Interventions: Advanced multimodal wireless vital signs monitor; Device
Lead sponsor: Northwestern University; Other
Eligibility: 1 Year to 17 Years
Enrollment: 5 participants
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Menopause, Obesity, Abdominal, Aging, Weight Gain
Interventions: GnRH antagonist, Estrogen Product, Placebo estradiol, Placebo GnRH antagonist; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 40 Years to 65 Years · Female only
Enrollment: 57 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Lower Urinary Tract Symptoms, Overactive Bladder
Interventions: Fully integrated Uro-NIRS:UDS; Device
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: New York, New York

Conditions: Vitamin D Deficiency
Interventions: Transdermal D Patch, Oral vitamin D3, Placebo patch, Oral placebo; Dietary Supplement
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 85 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Chronic Low Back Pain
Interventions: Lidoderm®, Celecoxib; Drug
Lead sponsor: Endo USA Inc., a Keenova Therapeutics Company; Industry
Eligibility: 18 Years and older
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2004
U.S. locations: 21
States / cities: Northport, Alabama • Phoenix, Arizona • Beverly Hills, California + 18 more

Conditions: Tobacco Smoking, Psychiatric Disorder, Psychiatric Hospitalization
Interventions: Acceptance and Commitment Therapy, Enhanced Usual Care; Behavioral
Lead sponsor: The Miriam Hospital; Other
Eligibility: 18 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Amblyopia
Interventions: patching, binocular games; Other
Lead sponsor: Retina Foundation of the Southwest; Other
Eligibility: 4 Years to 14 Years
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2027
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Cumulative Irritation and Sensitization
Interventions: dATS; Drug
Lead sponsor: Noven Therapeutics; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 229 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Jersey City, New Jersey

Conditions: Cardiac Disease
Interventions: AI-Flex; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 85 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Cigarette Smoking
Interventions: Moderate intensity exercise, Health education; Behavioral
Lead sponsor: Brown University; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 113 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Eczema
Interventions: hydrogel patch, Triamcinolone (TAC) 0.1% cream; Device · Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Atopic Dermatitis
Interventions: ShA9 Topical Gel, Hydrocortisone Ointment, Clobetasol Ointment, Fluocinonide Ointment, Placebo (Vehicle) Topical Gel, Triamcinolone Ointment; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 6 Years and older
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 8
States / cities: San Diego, California • Denver, Colorado • Chicago, Illinois + 4 more

Conditions: Myeloma
Interventions: TempShield Continuous Temperature Monitoring, Standard of Care; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 2
States / cities: Charlotte, North Carolina • Winston-Salem, North Carolina

Conditions: Cigarette Smoking
Interventions: Nicotine Patch; Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 479 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Healthy Volunteers
Interventions: BMB72 (actA/plcB-deleted Listeria monocytogenes expressing influenza A nucleoprotein); Biological
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 55 Years
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

fMRI Study of Nicotinic Effect on Neurophysiology of Schizophrenia

Patient Status Engine (PSE): EARLY FEASIBILITY AND USABILITY STUDY

Partner Assistance in Learning and Performing Skin Self-Examination

Semaglutide for Post-Smoking Cessation Weight Management

Cardiometabolic Consequences of the Loss of Ovarian Function

Open Label, Safety Study of EN3270 in Patients With Moderate to Severe Non-malignant, Chronic Pain

Telerehabilitation Alzheimer's Disease Feasibility (TADF)

Analysis of Aldehyde Biomarkers of Exposure and Host Response

Role of Estrogen on Skeletal Outcomes in FHA

Advanced Multimodal Wireless Vital Signs Monitoring for Patients With Asthma and Anaphylaxis

Bioenergetic Effects of Aging and Menopause (BEAM)

Uro-NIRS Clinical Study

Evaluation of a Transdermal Vitamin D3 Delivery System, D3forME

Lidocaine Patch 5% Versus Celecoxib 200 mg in Chronic Axial Low Back Pain

Acceptance and Commitment Therapy for Tobacco Cessation Among Psychiatric Partial Hospital Patients

Binocular iPad Sub-Study

Irritation and Sensitization Study of d-Amphetamine Transdermal System

A Study of a Multi-Modal Sensor Patch for Real-Time Physiological Monitoring and Inference

Quit Smoking With Nicotine Patch and Exercise/Health Education (Females Only)

Hydrogel Patch for the Treatment of Eczema

Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)

Wearable Core Body Temperature Monitoring for Early Detection of Cytokine Release Syndrome in Outpatients Receiving CAR T-Cell Therapy

Concurrent Nicotine Patch / Denicotinized Cigarette Therapy for Smoking Cessation II

Transcutaneous Immunization With an Attenuated Listeria Monocytogenes Vector Vaccine